Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Taxus Express2 paclitaxel-eluting coronary stent is launched in Japan

Boston Scientific : 08 May, 2007  (New Product)
Boston Scientific has launched the Taxus Express2 paclitaxel-eluting coronary stent system in Japan.
The product was approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) on 30 March 2007; reimbursement has now been granted by the National Health Insurance System, effective 1 May 2007.

The Taxus Stent systems are currently the leading drug-eluting stents in markets outside of Japan.

The number of coronary stents implanted annually in Japan is estimated at 200,000, making it the largest market in the world outside of the USA.

The Taxus Stent systems have been evaluated by the industry's most extensive randomised, controlled clinical trial programme.

The Taxus Stent systems have also been studied in more than 12,000 real world patients enrolled in post-approval registries, in addition to three million Taxus stents implanted worldwide.

'Boston Scientific is committed to bringing the most innovative medical devices and procedures to the Japan market', said David W McFaul, president and representative director of Boston Scientific Japan.

'The Taxus Stent offers Japanese physicians a broader choice of Stent technologies and provides a deliverable treatment option with proven outcomes across a broad range of patients'.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo